Nelson L. Michael

34.6k total citations · 2 hit papers
269 papers, 8.6k citations indexed

About

Nelson L. Michael is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Nelson L. Michael has authored 269 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 192 papers in Virology, 146 papers in Infectious Diseases and 86 papers in Immunology. Recurrent topics in Nelson L. Michael's work include HIV Research and Treatment (191 papers), HIV/AIDS Research and Interventions (94 papers) and HIV/AIDS drug development and treatment (68 papers). Nelson L. Michael is often cited by papers focused on HIV Research and Treatment (191 papers), HIV/AIDS Research and Interventions (94 papers) and HIV/AIDS drug development and treatment (68 papers). Nelson L. Michael collaborates with scholars based in United States, Thailand and Germany. Nelson L. Michael's co-authors include Merlin L. Robb, Jérôme H. Kim, Deborah L. Birx, John R. Mascola, Linda L. Jagodzinski, Jintanat Ananworanich, Mark de Souza, Haynes W. Sheppard, Jean‐Louis Excler and Mary Marovich and has published in prestigious journals such as Science, New England Journal of Medicine and Cell.

In The Last Decade

Nelson L. Michael

262 papers receiving 8.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Central Nervous System Viral Invasion and Inflammation During Acute HIV Infection

2012 389 citations Mary Marovich, Nelson L. Michael et al. profile →
SARS-CoV-2 Variants in Patients with Immunosuppression

2021 263 citations Nelson L. Michael, Morgane Rolland et al. profile →

Peers

Countries citing papers authored by Nelson L. Michael

Since Specialization

Citations

This map shows the geographic impact of Nelson L. Michael's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nelson L. Michael with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nelson L. Michael more than expected).

Fields of papers citing papers by Nelson L. Michael

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nelson L. Michael. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nelson L. Michael. The network helps show where Nelson L. Michael may publish in the future.

Co-authorship network of co-authors of Nelson L. Michael

This figure shows the co-authorship network connecting the top 25 collaborators of Nelson L. Michael. A scholar is included among the top collaborators of Nelson L. Michael based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nelson L. Michael. Nelson L. Michael is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Afucosylation of anti-dengue IgG is associated with enhanced susceptibility to dengue virus infection postvaccination 2025 ·Science Translational Medicine ·Usama Ashraf, Saborni Chakraborty, (unknown), Nathan C. Lo, Maria Theresa Alera, (unknown), (unknown), Nelson L. Michael, Alan L. Rothman, Taia T. Wang	1
2	Differences in neutralizing antibody sensitivities and envelope characteristics indicate distinct antigenic properties of Nigerian HIV-1 subtype G and CRF02_AG 2024 ·Virology Journal ·Lindsay Wieczorek, David Chang, Eric Sanders‐Buell, Michelle Zemil, Elizabeth J. Martinez, (unknown), (unknown), Sebastian Molnar, (unknown), (unknown), Manhattan Charurat, (unknown), William A. Blattner, Michael Iroezindu, (unknown), Nelson L. Michael, Trevor A. Crowell, Julie A. Ake, Sodsai Tovanabutra, Victoria R. Polonis, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
3	Impact of HLA class I functional divergence on HIV control 2024 ·Science ·Mathias Viard, Colm Ó’hUigín, Yuko Yuki, Arman Bashirova, David R. Collins, Jonathan M. Urbach, Steven M. Wolinsky, Susan Buchbinder, Gregory D. Kirk, James J. Goedert, Nelson L. Michael, David W. Haas, Steven G. Deeks, Bruce D. Walker, Xu G. Yu, Mary Carrington	6
4	Young at risk-people in Maputo City, Mozambique, present a high willingness to participate in HIV trials: Results from an HIV vaccine preparedness cohort study 2021 ·PLoS ONE ·(unknown), (unknown), (unknown), Nilesh Bhatt, (unknown), Mark Milazzo, (unknown), Trevor A. Crowell, Nelson L. Michael, Merlin L. Robb, Ilesh Jani, Arne Kroidl, Christina S. Polyak, Caroline De Schacht, (unknown)	2
5	Factors associated with testing for HIV and hepatitis C among behaviorally vulnerable men in Germany: a cross-sectional analysis upon enrollment into an observational cohort 2021 ·AIDS Research and Therapy ·Trevor A. Crowell, Haoyu Qian, Carsten Tiemann, Clara Lehmann, Christoph Boesecke, Albrecht Stoehr, (unknown), Stefan Eßer, Markus Bickel, Christoph D. Spinner, (unknown), (unknown), Norbert H. Brockmeyer, Heiko Jessen, Merlin L. Robb, Nelson L. Michael, Klaus Jansen, Hendrik Streeck, (unknown)	3
6	Impact of prior Dengue immunity on Zika vaccine protection in rhesus macaques and mice 2021 ·PLoS Pathogens ·Rafael A. Larocca, Peter Abbink, John D. Ventura, Abishek Chandrashekar, Noe B. Mercado, (unknown), Erica N. Borducchi, Rafael A. De La Barrera, Kenneth H. Eckels, Kayvon Modjarrad, Michael P. Busch, Nelson L. Michael, Dan H. Barouch	7
7	A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants 2020 ·Proceedings of the National Academy of Sciences ·Bethany L. Dearlove, Éric Lewitus, Hongjun Bai, Yifan Li, Daniel B. Reeves, Michael Joyce, Paul T. Scott, Mihret F. Amare, Sandhya Vasan, Nelson L. Michael, Kayvon Modjarrad, Morgane Rolland	127
8	Determining hematological, biochemical and immunological reference values in healthy adults with high-risk for HIV acquisition in Mozambique 2020 ·PLoS ONE ·(unknown), (unknown), (unknown), (unknown), Leigh Anne Eller, John Lawlor, Mark Milazzo, Qun Li, Trevor A. Crowell, (unknown), (unknown), (unknown), (unknown), (unknown), Nelson L. Michael, Merlin L. Robb, Christina S. Polyak, Ilesh Jani, Nilesh Bhatt	2
9	Disclosure of Same-Sex Sexual Practices to Family and Healthcare Providers by Men Who Have Sex with Men and Transgender Women in Nigeria 2020 ·Archives of Sexual Behavior ·Afoke Kokogho, (unknown), Stefan Baral, Manhattan Charurat, Sylvia Adebajo, (unknown), (unknown), (unknown), Nelson L. Michael, Merlin L. Robb, Julie A. Ake, Rebecca G. Nowak, Trevor A. Crowell, (unknown)	18
10	CTL Clonotypes with Higher TCR Affinity Have Better Ability to Reduce the HIV Latent Reservoir 2020 ·The Journal of Immunology ·Noemia S. Lima, Hiroshi Takata, Szu-Han Huang, (unknown), Julie L. Mitchell, Stephen Blackmore, (unknown), (unknown), (unknown), Jean‐Pierre Routy, Nelson L. Michael, Victor Appay, R. Brad Jones, Lydie Trautmann	7
11	HIV prevalence and risk behavior among male and female adults screened for enrolment into a vaccine preparedness study in Maputo, Mozambique 2019 ·PLoS ONE ·(unknown), Nilesh Bhatt, (unknown), Leigh Anne Eller, (unknown), (unknown), (unknown), Qun Li, Mark Milazzo, Nancy K. Hills, Christina Lindan, Nelson L. Michael, Merlin L. Robb, Ilesh Jani, Christina S. Polyak	6
12	A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trials 2019 ·Science Translational Medicine ·Philip K. Ehrenberg, (unknown), Biju Issac, Galit Alter, Aviva Geretz, T Izumi, Christopher Bryant, Michael A. Eller, Frank Wegmann, Richard Apps, (unknown), Diane L. Bolton, Rafick‐Pierre Sékaly, Merlin L. Robb, Robert Gramzinski, Maria Grazia Pau, Hanneke Schuitemaker, Dan H. Barouch, Nelson L. Michael, Rasmi Thomas	17
13	Prevention of SIVmac251 reservoir seeding in rhesus monkeys by early antiretroviral therapy 2018 ·Nature Communications ·James B. Whitney, So‐Yon Lim, Christa E. Osuna, (unknown), (unknown), (unknown), Po-Ting Liu, Peter Abbink, (unknown), Alison L. Hill, Mark G. Lewis, Romas Geleziunas, Merlin L. Robb, Nelson L. Michael, Dan H. Barouch	44
14	Priming and Activation of Inflammasome by Canarypox Virus Vector ALVAC via the cGAS/IFI16–STING–Type I IFN Pathway and AIM2 Sensor 2017 ·The Journal of Immunology ·Feng‐Liang Liu, Qingli Niu, Xiuzhen Fan, (unknown), Jie Zhang, Zhi Wei, Wei Hou, Thirumala‐Devi Kanneganti, Merlin L. Robb, Jérôme H. Kim, Nelson L. Michael, Jiaren Sun, Lynn Soong, Haitao Hu	31
15	Distinct gene-expression profiles associated with the susceptibility of pathogen-specific CD4 T cells to HIV-1 infection 2012 ·Blood ·Haitao Hu, Martin E. Nau, Philip K. Ehrenberg, (unknown), Camila Macedo, Yu Zhou, Z. John Daye, Zhi Wei, Maryanne Vahey, Nelson L. Michael, Jérôme H. Kim, Mary Marovich, Silvia Ratto‐Kim	35
16	B Cell Depletion in HIV-1 Subtype A Infected Ugandan Adults: Relationship to CD4 T Cell Count, Viral Load and Humoral Immune Responses 2011 ·PLoS ONE ·(unknown), Britta Flach, Leigh Anne Eller, Michael A. Eller, Benson J. Ouma, Mark de Souza, Hannah Kibuuka, Fred Wabwire‐Mangen, Bruce K. Brown, Nelson L. Michael, Merlin L. Robb, David C. Montefiori, Victoria R. Polonis	4
17	Identification of CRF34_01B, a Second Circulating Recombinant Form Unrelated to and More Complex Than CRF15_01B, among Injecting Drug Users in Northern Thailand 2007 ·AIDS Research and Human Retroviruses ·Sodsai Tovanabutra, Gustavo H. Kijak, Chris Beyrer, (unknown), Supachai Sakkhachornphop, Tasanai Vongchak, Jaroon Jittiwutikarn, Myat Htoo Razak, Eric Sanders‐Buell, Merlin L. Robb, Vinai Suriyanon, Deborah L. Birx, Nelson L. Michael, David D. Celentano, Francine E. McCutchan	54
18	Effects of CCR5-Δ32 and CCR2-64I alleles on HIV-1 disease progression 2003 ·AIDS ·(unknown), Thomas R. OʼBrien, John P. A. Ioannidis, James J. Goedert, Susan Buchbinder, Roel A. Coutinho, Beth D. Jamieson, Laurence Meyer, Nelson L. Michael, Giuseppe Pantaleo, G. Paolo Rizzardi, Hanneke Schuitemaker, Haynes W. Sheppard, Ioannis Theodorou, David Vlahov, Philip S. Rosenberg	78
19	Demonstration of de Novo HIV Type 1 Production by Detection of Multiply Spliced and Unspliced HIV Type 1 RNA in Paraffin-Embedded Tonsils 2002 ·AIDS Research and Human Retroviruses ·Elena F. Brachtel, John R. Mascola, Douglas J. Wear, Philip K. Ehrenberg, (unknown), Eric Sanders‐Buell, Nelson L. Michael, Sarah S. Frankel	5
20	Expression of the Mouse Mitochondrial DNA Genome 1982 ·Cold Spring Harbor Monograph Archive ·Richard A. Van Etten, Nelson L. Michael, Maureen J. Bibb, Axel Brennicke, David A. Clayton	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact